Posted On: 12/16/2015 1:51:07 PM
Post# of 72440
I suggest you to read the latest 10-Q. It’ll tell you how much are the trials and where the money will come from.
Dilutions are part of the game for early biotechs. If the company is acquired, the SP will be based on fully diluted shares anyway.
You seem to ignore the possibility of a partnership for either Prurisol or Kevetrin in 2016. Why so pessimistic?
Dilutions are part of the game for early biotechs. If the company is acquired, the SP will be based on fully diluted shares anyway.
You seem to ignore the possibility of a partnership for either Prurisol or Kevetrin in 2016. Why so pessimistic?
(0)
(0)
Scroll down for more posts ▼
